newsfilter
← Latest News
GlobeNewswire·

Collegium to Report Fourth Quarter and Full-Year 2025 Financial Results on February 26, 2026

STOUGHTON, Mass., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (NASDAQ:COLL) today announced that it will report fourth quarter and full-year 2025 financial results before the market opens